Showing results (41-50 of 142) with videos related to

Sort By:
Pageof 15
Brain Sciences|September 23, 2022
Epidemiology of Progressive Supranuclear Palsy: Real World Data from the Second Largest Health Plan in IsraelYael Barer, Gabriel Chodick, Raanan Cohen, et al.
Parkinsonism & Related Disorders|May 11, 2016
Cancer incidence among Parkinson's disease patients in a 10-yrs time-window around disease onset: A large-scale cohort studyChava Peretz, Ron Gurel, Violet Rozani, et al.
Neuroepidemiology|June 17, 2019
The Modifying Effect of Age on Survival in Parkinson's Disease: A Population-Based Cohort StudyChava Peretz, Violetta Rozani, Nir Giladi, et al.
Parkinsonism & Related Disorders|March 30, 2019
Anemia in men and increased Parkinson's disease risk: A population-based large scale cohort studyVioletta Rozani, Nir Giladi, Tanya Gurevich, et al.
Clinical Parkinsonism & Related Disorders|July 27, 2023
Healthcare utilization, costs, and epidemiology of Huntington's disease in IsraelYael Barer, Rinat Ribalov, Ayelet Yaari, et al.
Emotion (Washington, D.C.)|April 14, 2017
Gently does it: Humans outperform a software classifier in recognizing subtle, nonstereotypical facial expressionsNeta Yitzhak, Nir Giladi, Tanya Gurevich, et al.
Plos One|February 6, 2013
White matter hyperintensities in Parkinson's disease: do they explain the disparity between the postural instability gait difficulty and tremor dominant subtypes?Talia Herman, Keren Rosenberg-Katz, Yael Jacob, et al.
Parkinsonism & Related Disorders|October 8, 2018
Single center experience with medical cannabis in Gilles de la Tourette syndromeAvner Thaler, Shira Arad, Lihi Bar-Lev Schleider, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|June 12, 2025
Cognitive effects of a single dose of methylphenidate in Parkinson's disease patients using electrophysiological measuresNoa Fogelson, Estela Martinez Lopez, Mirian Roson Gonzalez, et al.
Parkinsonism & Related Disorders|October 7, 2021
ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: A randomized, placebo-controlled phase 2 studyNir Giladi, Tanya Gurevich, Ruth Djaldetti, et al.
Pageof 15